Eli Lilly has signed a multi-year exclusive collaboration deal with Israel-based Anima Biotech, as the drugmaker continues to push for new avenues of drug development.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.